Author, Subjects, Keywords

Cited Author

 
 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » Malaysian Journals
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top Journal Cited
 » Top Article Cited
 » Journal Citation Statistics
 » Usage Since Sept 2007


 
 
 

Login | Create Account

Long Term Outcome of Renal Allografts in Patients with Immunoglobulin A Nephropathy

Ng, Y.S., and Vathsala, A., and Chew, Stephen T.H., and Chiang, Gilbert S.C., and Woo, K.T., (2007) Long Term Outcome of Renal Allografts in Patients with Immunoglobulin A Nephropathy. Medical Journal of Malaysia, 62 (2). pp. 109-113. ISSN 0300-5283

Full text not available from this repository.

Affiliations

Fatimah Hospital, Ipoh.
Singapore General Hospital. Dept. of Renal Medicine.
Mount Elizabeth Medical Centre, Singapore.
Singapore General Hospital. Dept. of Pathology.
Singapore General Hospital. Dept. of Renal Medicine.

Abstract

Recurrent glomerular disease is an important cause of late allograft loss in renal transplant recipients. Immunoglobulin A nephropathy (lgAN) is a leading cause of end-stage renal disease (ESRD) worldwide and its recurrence has been reported in allografts. The present study examined outcomes following renal transplantation (RTX) in 101 patients with ESRD due to biopsy-proven IgAN, in comparison to non-IgA patients, and evaluated the incidence of recurrence. The study population (mean age 34.8 ± 7.7 years; males 62.2%; Chinese 88.3%) underwent RTX under CsA immunosuppression between November 1934 and December 2004; as two patients underwent retransplantation during the study period, 103 allografts (56.3% cadaveric) were included for retrospective analysis. At time of analysis on 1 January 2005, 78 (75.7%) renal allografts (IgAN RTX) were functioning, of which 51(49.5%) had normal serum creatinine, 27 (26.2%) had chronic allograft dysfunction, while 25 had graft losses, either due to patient death with functioning grafts (5.8%) or withdrawal to dialysis (18.5%). Persistent microscopic haematuria, not attributable to other causes or proteinuria > 1 g/day occurred in 42.7% and 13.6% of allografts respectively. Of 29 allografts biopsied for evaluation of proteinuria and/or renal dysfunction post-RTX, 8 (27.6%) had IgAN (overall histological recurrence, 7.8%). Of these, three had graft loss due to recurrent IgAN, three had elevated serum creatinine, while two had normal serum creatinine. Overall five and ten year patient survivals for IgAN RTX were 95.3% and 82.2%, and five and ten year actuarial graft survivals were 82.3% and 67.8% respectively. Five and ten year patient and graft survivals for IgAN RTX were not significantly different from that for non-IgAN RTX. In summary, RTX patients with IgAN have a low incidence of documented histological recurrence and recurrence contributing to graft loss occurs in only 2.9%. These results suggest that RTX is an excellent modality of renal replacement therapy in this population.

Item Type:Journal
Keywords:Histological recurrence, Renal biopsy, Cyclosporine, Survivals, Recurrent glomerular diseases
Subjects:R Medicine, Dentistry, Pharmacy, Nursing
ID Code:6015

1. Hariharan S, Peddi VR, Savin VJ et al. Recurrent and de novo renal diseases after renal transplantation: A report from the renal allograft disease registry. Am J Kidney Dis 1998; 31: 928.

2. G D’Amico. Epidemiological, clinical and prognostic indices in IgA nephropathy. Nephrology 1997; 3: 13.

3. Woo KT, Chiang GSC. Glomerulonephritis in Singapore (1987-1997). Medicine of the Americas 2000: 1: 30.

4. Woo KT, Chiang GS, Pall A, Tan PH, Chin YM. The changing pattern of glomerulonephritis in Singapore over the past two decades. Clin Nephrol 1999; 52: 96.

5. Bergec J, Noel LH, Nabarra B. Recurrence of mesangial IgA nephropathy after renal transplantation. Contr Nephrol 1984; 40: 195.

6. Bachman U, Biava C, Amend W et al. The clinical course of IgA nephropathy and Henoch-Schonlein purpura following renal transplantation. Transplantation 1986; 42: 511.

7. Odum J, Peh CA, Clarkson AR et al. Recurrent mesangial IgA nephritis following renal transplantation. Nephrol Dial Transplant 1994; 9: 309.

8. Andresdottir MB, Hoitsma AJ, Assmann KJM, Wetzels JFM. Favorable outcome of renal transplantation in patients with IgA nephropathy. Clinical Nephrology 2001; 56: 279.

9. Kotanko P, Pusey CD, Levy JB. Recurrent glomerulonephritis following renal transplantation. Transplantation 1997; 63: 1045.

10. Floege J, Burg M, Klien V. Recurrent IgA nephropathy after kidney transplantation: not a benign condition. Nephrol Dial Transplant 1998; 13: 1933.

11. Frohnert PP, Donadio JV Jr, Velosa JA, Holley RE, Sterioff S. The fate of renal transplants in patients with IgA nephropathy. Clin Transplant 1997; 11: 127.

12. Vathsala A, Woo KT. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital. Clinical Transplants 1999, Cecka ann Terasaki eds. UCLA Immunogenetics Center, Los Angeles, California. 189.

13. Wang AY, Lai FM, Yu AW et al. Recurrent IgA nephropathy in renal transplant allografts. Am J Kidney Dis 2001; 38: 588.

14. Woo KT, Edmondson RP, Wu AY, Chiang CS, Pwee HS, Lim CH. The natural history of IgA nephritis in Singapore. Clin Nephrol 1986; 25: 15.

15. Bumgardner GL, Amend WC, Ascher NL, Vincenti FG. Single-center long-term results of renal transplantation for IgA nephropathy. Transplantation 1998; 65: 1053.

16. Tomlanovich S, Vincenti F, Amend W et al. Is cyclosporine effective in preventing recurrence of immune-mediated glomerular disease after renal transplantation? Transplant Proc 1988; 20: 285.

17. Kessler M, Hiesse C, Hestin D, Mayeux D, Boubenider K, Charpentier B. Recurrence of immunoglobulin A nephropathy after renal transplantation in the cyclosporin era. Am J Kidney Dis 1996; 28: 99.

18. Lai KN, Lai FM, Li PK, Vallance-Owen J. Cyclosporine treatment of IgA nephropathy: a short term controlled study. Br Med J (Clin Res Ed) 1987; 295: 1165.

19. Ohmacht C, Kliem V, Burg M et al. Recurrent immunoglobulin A nephropathv after renal transplantation: a significant contributor to graft loss. Transplantation 1997; 64: 1493.

20. Lim EC, Terasaki PI. High survival rate of kidney transplants in IgA nephropathy patients. Clin Transplants 1992; 6: 100.

21. Lim EC, Chia D, Gjertson DW, Prasad K, Terasaki PI. In vitro studies to explain high renal allograft survival in IgA nephcopathy patients. Transplantation 1993; 55: 996.

22. Brensilver JM, Mallat S, Sholes J, McCabe R. Recurrent IgA nephropathy in living-related donor transplantation: Recurrence or transmission of familial disease? Am J Kidney Dis 1988; 12: 147.

Repository Staff Only: item control page
 
 
 
 
 
 
© Copyright 2007 MyAIS Faculty of Computer Science and Information Technology, University of Malaya – All Rights Reserved. Malaysian Abstracting and Indexing System is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.